Cadrenal Therapeutics, Inc.
CVKD
$15.50
-$0.775-4.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -27.45% | 40.71% | 51.36% | 60.66% | -14.10% |
| Total Depreciation and Amortization | -5.00% | -8.70% | 4.55% | 50.00% | 42.86% |
| Total Amortization of Deferred Charges | -- | -100.00% | -100.00% | -100.00% | -81.37% |
| Total Other Non-Cash Items | -69.60% | -91.87% | -93.68% | -93.83% | -11.49% |
| Change in Net Operating Assets | 1,198.20% | 182.64% | 2,131.03% | 692.95% | -78.23% |
| Cash from Operations | -108.41% | -93.51% | -54.94% | -47.35% | -168.63% |
| Capital Expenditure | -96.97% | 100.00% | 100.00% | -32.00% | -32.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -96.97% | 100.00% | 100.00% | -32.00% | -32.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 100.00% | 100.00% | -- |
| Issuance of Common Stock | -57.72% | -87.44% | 14.99% | 14.98% | 139,739.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -24.56% | -87.63% | 4.69% | 3.84% | 780.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -80.70% | -152.67% | -43.04% | -28.89% | 23,477.18% |